CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade

Tang,Zong‑Sheng; Hao,You‑Hua; Zhang,E‑Juan; Xu,Chun‑Li; Zhou,Yun; Zheng,Xin; Yang,Dong‑Liang

doi:10.3892/mmr.2016.5396

CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade

Authors:
- Zong‑Sheng Tang
- You‑Hua Hao
- E‑Juan Zhang
- Chun‑Li Xu
- Yun Zhou
- Xin Zheng
- Dong‑Liang Yang
View Affiliations

Affiliations: Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China, Division of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, P.R. China
Published online on: June 13, 2016 https://doi.org/10.3892/mmr.2016.5396
Pages: 1107-1116
Copyright: © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the overall clinical expression characteristics of the cluster of differentiation (CD)28 family receptors [CD28, inducible T-cell co-stimulator, programmed cell death protein 1 (PD‑1), cytotoxic T-lymphocyte-associated protein 4 and B‑ and T-lymphocyte attenuator] on T cells in patients with chronic hepatitis B (CHB), analyze the correlations among these receptors and the clinical parameters, and to investigate the effects of PD‑1 blockade on the receptor expression profiles, T‑cell function and other biological effects. The expression characteristics of the CD28 family of receptors, the effects of PD‑1 blockade on the receptor expression profiles and the levels of interferon (IFN)‑γ were investigated in the T cells of patients with CHB. In addition, the transcription factor, T‑box 21 (T‑bet) and GATA binding protein 3 (GATA‑3) mRNA expression levels were investigated in the peripheral blood mononuclear cells (PBMCs) of patients with CHB. The expression levels of the CD28 family receptors in the T cells of patients with CHB demonstrated distinct characteristics , for example levels of PD‑1 and CTLA‑4 on CD4 T cells and ICOS, PD‑1, and BTLA on CD8 T cells were increased in cells from patients with CHB compared with those from the healthy individuals. A significant positive correlation was demonstrated among the serum HBV DNA titers and the levels of PD‑1 on CD8+ T cells with the highest expression of PD‑1 corresponding to viral levels >106 IU/ml. A significant positive correlation was observed between the serum HBV DNA titers and the expression levels of BTLA on CD8+ T cells with the highest expression of BTLA corresponding to viral levels >106 IU/ml. PD‑1 blockade altered the expression profiles of CD28 family receptors in the T cells of patients with CHB, partly enhanced T cell function and increased the ratio of T‑bet/GATA‑3 mRNA in PBMCs. Thus, CD28 family receptors are potential clinical indicators for the rapid monitoring of changes in T cell function during CHB treatment. Furthermore, PD‑1 blockade has a therapeutic potential that may be enhanced by modulating the expression of co-stimulatory and -inhibitory receptors of the CD28 family.

View Figures

View References

1	Yi JS, Cox MA and Zajac AJ: T-cell exhaustion: Characteristics, causes and conversion. Immunology. 129:474–481. 2010. View Article : Google Scholar : PubMed/NCBI
2	Wherry EJ: T cell exhaustion. Nat Immunol. 12:492–499. 2011. View Article : Google Scholar : PubMed/NCBI
3	Crawford A and Wherry EJ: The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr Opin Immunol. 21:179–186. 2009. View Article : Google Scholar : PubMed/NCBI
4	Chen L and Flies DB: Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 13:227–242. 2013. View Article : Google Scholar : PubMed/NCBI
5	Carreno BM, Carter LL and Collins M: Therapeutic opportunities in the B7/CD28 family of ligands and receptors. Curr Opin Pharmacol. 5:424–430. 2005. View Article : Google Scholar : PubMed/NCBI
6	Anand S and Chen L: Control of autoimmune diseases by the B7-CD28 family molecules. Curr Pharm Des. 10:121–128. 2004. View Article : Google Scholar : PubMed/NCBI
7	Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ and Jiang YF: Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B. Antimicrob Agents Chemother. 57:1304–1311. 2013. View Article : Google Scholar : PubMed/NCBI
8	Zelinskyy G, Myers L, Dietze KK, Gibbert K, Roggendorf M, Liu J, Lu M, Kraft AR, Teichgräber V, Hasenkrug KJ and Dittmer U: Virus-specific CD8⁺ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol. 187:3730–3737. 2011. View Article : Google Scholar : PubMed/NCBI
9	Tassiopoulos K, Landay A, Collier AC, Connick E, Deeks SG, Hunt P, Lewis DE, Wilson C and Bosch R: CD28-negative CD4⁺ and CD8⁺ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies. J Infect Dis. 205:1730–1738. 2012. View Article : Google Scholar : PubMed/NCBI
10	Schurich A, Khanna P, Lopes AR, Han KJ, Peppa D, Micco L, Nebbia G, Kennedy PT, Geretti AM, Dusheiko G and Maini MK: Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology. 53:1494–1503. 2011. View Article : Google Scholar : PubMed/NCBI
11	Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J, Peppa D, Gilson RJ, Gehring A, Bertoletti A and Maini MK: Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest. 118:1835–1845. 2008. View Article : Google Scholar : PubMed/NCBI
12	Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, Cavallo MC, Silini EM, Andreone P, Missale G and Ferrari C: Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology. 138:682–693. 693.e1–e4. 2010. View Article : Google Scholar
13	Schurich A, Pallett LJ, Lubowiecki M, Singh HD, Gill US, Kennedy PT, Nastouli E, Tanwar S, Rosenberg W and Maini MK: The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog. 9:e10032082013. View Article : Google Scholar : PubMed/NCBI
14	Bengsch B, Martin B and Thimme R: Restoration of HBV-specific CD8⁺ T-cell function by PD-1 blockade in inactive carrier patients is linked to T-cell differentiation. J Hepatol. 61:1212–1219. 2014. View Article : Google Scholar : PubMed/NCBI
15	Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association: The guideline of prevention and treatment for chronic hepatitis B (2010 version). Zhonghua Gan Zang Bing Za Zhi. 19:13–24. 2011.In Chinese.
16	Bunce M: PCR-sequence-specific primer typing of HLA class I and class II alleles. Methods Mol Biol. 210:143–171. 2003.
17	Mikami N and Sakaguchi S: CD28 signals the differential control of regulatory T cells and effector T cells. Eur J Immunol. 44:955–957. 2014. View Article : Google Scholar : PubMed/NCBI
18	Deng M, Li MH, Liu SA, Liu F, Sang Y, Song SJ, Zang SF, Guan XP, Yao X, Wu XP, et al: Studies about the level of CD4⁺ CD25⁺ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 24:21–23. 2010.In Chinese. PubMed/NCBI
19	Sojka DK, Hughson A and Fowell DJ: CTLA-4 is required by CD4⁺CD25⁺ Treg to control CD4⁺ T-cell lymphopenia-induced proliferation. Eur J Immunol. 39:1544–1551. 2009. View Article : Google Scholar : PubMed/NCBI
20	Li M, Sun XH, Zhu XJ, Jin SG, Zeng ZJ, Zhou ZH, Yu Z and Gao YQ: HBcAg induces PD-1 upregulation on CD4⁺T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Lab Invest. 92:295–304. 2012. View Article : Google Scholar
21	Liu XY, Shi F, Zhao H and Wang HF: Research of PD-1 expression in CD8⁺ T cell of peripheral blood with HBV-associated acute-on-chronic liver failure. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 24:125–127. 2010.In Chinese. PubMed/NCBI
22	Prendergast A, Klenerman P and Goulder P: Expression of inducible costimulator (ICOS) on T cells is associated with HIV disease progression. Aids Research and Human Retroviruses. 24:1302008.
23	Jurado JO, Pasquinelli V, Alvarez IB, Martínez GJ, Laufer N, Sued O, Cahn P, Musella RM, Abbate E, Salomón H and Quiroga M: ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis. J Int AIDS Soc. 15:174282012. View Article : Google Scholar : PubMed/NCBI
24	Rudd CE, Taylor A and Schneider H: CD28 and CTLA 4 coreceptor expression and signal transduction. Immuno Rev. 229:12–26. 2009. View Article : Google Scholar
25	van Berkel ME and Oosterwegel MA: CD28 and ICOS: Similar or separate costimulators of T cells? Immunol Lett. 105:115–122. 2006. View Article : Google Scholar : PubMed/NCBI
26	Simpson TR, Quezada SA and Allison JP: Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr Opin Immunol. 22:326–332. 2010. View Article : Google Scholar : PubMed/NCBI
27	Nan XP, Zhang Y, Yu HT, Li Y, Sun RL, Wang JP and Bai XF: Circulating CD4⁺CD25 ^high regulatory T cells and expression of PD-1 and BTLA on CD4⁺ T cells in patients with chronic hepatitis B virus infection. Viral Immunol. 23:63–70. 2010. View Article : Google Scholar : PubMed/NCBI
28	Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, et al: BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol. 4:670–679. 2003. View Article : Google Scholar : PubMed/NCBI
29	Otsuki N, Kamimura Y, Hashiguchi M and Azuma M: Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochem Biophys Res Commun. 344:1121–1127. 2006. View Article : Google Scholar : PubMed/NCBI
30	Maini MK and Schurich A: The molecular basis of the failed immune response in chronic HBV: Therapeutic implications. J Hepatol. 52:616–619. 2010. View Article : Google Scholar : PubMed/NCBI
31	Brooks DG, Teyton L, Oldstone MB and McGavern DB: Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol. 79:10514–10527. 2005. View Article : Google Scholar : PubMed/NCBI
32	Trautmann T, Kozik JH, Carambia A, Richter K, Lischke T, Schwinge D, Mittrücker HW, Lohse AW, Oxenius A, Wiegard C and Herkel J: CD4⁺ T-cell help is required for effective CD8⁺ T cell-mediated resolution of acute viral hepatitis in mice. PLoS One. 9:e863482014. View Article : Google Scholar
33	Chakir H, Wang H, Lefebvre DE, Webb J and Scott FW: T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: Predominant role of GATA-3. J Immunol Methods. 278:157–169. 2003. View Article : Google Scholar : PubMed/NCBI
34	Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP and Glimcher LH: Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science. 295:338–342. 2002. View Article : Google Scholar : PubMed/NCBI
35	Nasta F, Ubaldi V, Pace L, Doria G and Pioli C: Cytotoxic T-lymphocyte antigen-4 inhibits GATA-3 but not T-bet mRNA expression during T helper cell differentiation. Immunology. 117:358–367. 2006. View Article : Google Scholar : PubMed/NCBI